Arab Finance: Minapharm Pharmaceuticals will pay the EGP 2.8 per share dividends to shareholders for 2022 on July 10^th, according to a statement filed to the Egyptian Exchange (EGX) on July 5^th.

The eligibility in distribution to shareholders will be until July 5^th’s trading session.

It is worth mentioning that the firm previously reported a 61.74% year-on-year (YoY) leap in consolidated net profit attributable to the parent company for the first quarter (Q1) of 2023, registering EGP 49.928 million.

Minapharm Pharmaceuticals is an Egypt-based company engaged in the production and distribution of pharmaceutical products.

Canal Shipping Agencies unveils cash dividends for FY2024/25 Updated 12/2/2025 12:42:00 PM

Minapharm's net profits fall 22.7% YoY in 9 months Updated 11/30/2025 2:25:00 PM

Eastern Company to pay EGP 2.85/share cash dividend for FY2024/25 Updated 11/25/2025 9:50:00 AM

Minapharm, Bayer cooperate to localize drug production in Egypt Updated 11/16/2025 9:52:00 AM

Wadi Kom Ombo's OGM approves cash dividend of EGP 15.07 per share Updated 11/9/2025 11:57:00 AM